Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

4,381 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,381 results

Not applicableActive Not RecruitingNCT05623787
What this trial is testing

Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesAppendix Cancer+2 more
Laval University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06807606
What this trial is testing

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 35
Not applicableUnknownNCT00607984
What this trial is testing

Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors

Who this might be right for
Central Nervous System TumorsTumors
Rabin Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00994643
What this trial is testing

Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma

Who this might be right for
High Risk Non-Hodgkin's Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 11
Early research (Phase 1)Study completedNCT01149915
What this trial is testing

Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+3 more
Threshold Pharmaceuticals 40
Testing effectiveness (Phase 2)UnknownNCT05602415
What this trial is testing

Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaHigh Risk of RecurrenceAnlotinib+1 more
Ruijin Hospital 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07169617
What this trial is testing

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Who this might be right for
Lung Carcinoma
National Cancer Institute (NCI) 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05943106
What this trial is testing

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

Who this might be right for
Non-Muscle- Invasive Bladder Cancer
AstraZeneca 100
Testing effectiveness (Phase 2)Looking for participantsNCT01906385
What this trial is testing

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Who this might be right for
Glioma
Cerenome 55
Testing effectiveness (Phase 2)Study completedNCT00003335
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Case Comprehensive Cancer Center 44
Very early researchStudy completedNCT03358563
What this trial is testing

Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 30
Testing effectiveness (Phase 2)Temporarily pausedNCT06211933
What this trial is testing

Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)

Who this might be right for
Non-Resectable Pancreas Carcinoma
Centre Leon Berard 26
Post-approval studies (Phase 4)Study completedNCT04590521
What this trial is testing

HPV Vaccine Immunity in High-risk Women

Who this might be right for
HPV Infection
Murdoch Childrens Research Institute 63
Testing effectiveness (Phase 2)Looking for participantsNCT06971614
What this trial is testing

T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

Who this might be right for
Nonmuscle-invasive Bladder Cancer
ImmVira Pharma Co. Ltd 160
Testing effectiveness (Phase 2)Looking for participantsNCT07223385
What this trial is testing

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer Stage IVCV Risk
Cedars-Sinai Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT00004147
What this trial is testing

COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Early research (Phase 1)Study completedNCT00074243
What this trial is testing

CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT04044209
What this trial is testing

The IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDS

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Yale University
Not applicableEnrolling By InvitationNCT06646263
What this trial is testing

Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies

Who this might be right for
Triple Negative Breast Cancer
Institute of Applied Biosciences 150
Testing effectiveness (Phase 2)Ended earlyNCT00004221
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer

Who this might be right for
Malignant Ovarian Mixed Epithelial TumorOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid Adenocarcinoma+5 more
Gynecologic Oncology Group 12
Next Page